Analysis for Bausch Health Companies
Description & usage
Bausch Health develops and markets pharmaceuticals focused on gastroenterology, eye care, and specialty therapies. The company benefits from established product portfolios and global commercialization infrastructure. Key drivers are core-product revenue trends, deleveraging progress, pipeline updates, and margin quality.
Basic info
- Symbol
- BHC
- Type
- Stock
- Region
- Global
- Sector
- Health Care
- Available history
- 11.2 years
- Last trading day
- 04/02/2026
Basic info
- Symbol
- BHC
- Type
- Stock
- Region
- Global
- Sector
- Health Care
- Available history
- 11.2 years
- Last trading day
- 04/02/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Analysis summary
Technical asset picture
Bausch Health Companies (BHC) currently has a total score of 10 points, placing it in the very weak range. The score is made up of Performance (5), Stability (12) and Trend (20). All three sub-scores are currently below average.
Performance scores 5 points (very weak). Least weak metric: 1Y return at -14.4 %. Main drag: 10Y return at -82.8 %. This points to a sharper upswing more recently.
Stability scores 12 points (very weak). Least weak metric: Sharpe ratio (90d) at -0.39. Main drag: max drawdown (10Y) at -96.7 %. That indicates very deep historical drawdowns. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 20 points (weak). Trend signals are mostly negative right now. Least weak signal: Price is about 4.6 % below SMA50. Main drag: Price is about 14.4 % below SMA100.
Overall, the picture is very weak: none of the three dimensions shows a clear strength. On a metric level, SMA50 distance stands out, while 10Y return lags.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: ISM PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.